Search

Your search keyword '"Niccoli P"' showing total 13 results
Start Over Author "Niccoli P" Journal annals of oncology
13 results on '"Niccoli P"'

2. 567O First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib

Author

Baudin, E., primary, Goichot, B., additional, Berruti, A., additional, Hadoux, J., additional, Moalla, S., additional, Laboureau, S., additional, Noelting, S., additional, de la Fouchardière, C., additional, Kienitz, T., additional, Deutschbein, T., additional, Zovato, S., additional, Amar, L., additional, Tabarin, A., additional, Timmers, H.J., additional, Niccoli, P., additional, Faggiano, A., additional, Beuschlein, F., additional, Attard, M., additional, Texier, M., additional, and Fassnacht, M., additional

Published
2021
Full Text
View/download PDF

3. LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network

Author

Walter, T., Lecomte, T., Hadoux, J., Niccoli, P., Saban-Roche, L., Gaye, E., Guimbaud, R., Baconnier, M., Hautefeuille, V., Do Cao, C., Petorin, C., Hentic Dhome, O., Perrier, M., Aparicio, T., Scoazec, J-Y., Lombard Bohas, C., Bin, S., Hervieu, V., Barritault, M., and Gerard, L.

Published
2023
Full Text
View/download PDF

4. 7O Updated results from phase I study of CC-90011 in patients (pts) with solid tumours (STs), including neuroendocrine neoplasms (NENs), and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Author

Hollebecque, A., primary, de Bono, J.S., additional, Salvagni, S., additional, Plummer, R., additional, Niccoli, P., additional, Capdevila, J., additional, Curigliano, G., additional, Moreno, V., additional, De Braud, F., additional, Gonzalez de Villambrosía, S., additional, Martin-Romano, P., additional, Baudin, E., additional, Arias, M., additional, De Alvaro, J., additional, Parra-Palau, J., additional, Sánchez-Pérez, T., additional, Aronchik, I., additional, Filvaroff, E., additional, Lamba, M., additional, and Nikolova, Z., additional

Published
2021
Full Text
View/download PDF

5. 528O CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Author

Hollebecque, A., primary, de Bono, J.S., additional, Salvagni, S., additional, Plummer, R., additional, Niccoli, P., additional, Capdevila, J., additional, Curigliano, G., additional, Moreno, V., additional, de Braud, F., additional, López-Brea, M., additional, Martin-Romano, P., additional, Baudin, E., additional, Arias, M., additional, de Alvaro, J., additional, Parra-Palau, J., additional, Sánchez-Pérez, T., additional, Aronchik, I., additional, Filvaroff, E., additional, Lamba, M., additional, and Nikolova, Z., additional

Published
2020
Full Text
View/download PDF

6. 18O CC-90011 in patients (Pts) with advanced solid tumors (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Author

Hollebecque, A., primary, de Bono, J.S., additional, Salvagni, S., additional, Plummer, R., additional, Niccoli, P., additional, Capdevila, J., additional, Curigliano, G., additional, Moreno, V., additional, De Braud, F., additional, López-Brea, M., additional, Martin-Romano, P., additional, Baudin, E., additional, Arias, M., additional, De Alvaro, J., additional, Parra-Palau, J., additional, Sánchez-Pérez, T., additional, Aronchik, I., additional, Filvaroff, E., additional, Lamba, M., additional, and Nikolova, Z., additional

Published
2020
Full Text
View/download PDF

7. LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study

Author

Walter, T.A., Lievre, A., Coriat, R., Malka, D., El Hajbi, F., Di Fiore, F., Dhome, O. Hentic, Smith, D., Hautefeuille, V., Roquin, G., Perrier, M., Dahan, L., V. Granger, Sobhani, I., Mineur, L., Niccoli, P., Assenat, E., Le Malicot, K., Lepage, C., and Bohas, C. Lombard

Published
2022
Full Text
View/download PDF

8. AcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types

Author

Marabelle, A., primary, Chevret, S., additional, Janot, F., additional, Escudier, B., additional, Pouessel, D., additional, Tournigand, C., additional, Hoang-Xuan, K., additional, Mortier, L., additional, Rousseau, B.J.-C., additional, Schlumberger, M.J., additional, Ray-Coquard, I.L., additional, Blay, J.-Y., additional, Niccoli, P., additional, Jaccard, A., additional, Couch, D., additional, Hoog-Labouret, N., additional, Pauporte, I., additional, and Massard, C., additional

Published
2018
Full Text
View/download PDF

11. Treatment Satisfaction, Symptom Control, and Quality of Life (Qol) with Lanreotide Autogel (Lan) in Neuroendocrine Tumour (Net) Patients with Carcinoid Syndrome (Cs): Results from the Symnet Study

Author

Ruszniewski, P., primary, Caplin, M., additional, Valle, J.W., additional, Lombard-Bohas, C., additional, Poston, G., additional, Perros, P., additional, Holubec, L., additional, Delle Fave, G., additional, Smith, D., additional, Niccoli, P., additional, Maisonobe, P., additional, and Atlan, P., additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results